Elafibranor

Elafibranor

CAT N°: 23508
Price:

From 48.00 40.80

Elafibranor is an agonist of the peroxisome proliferator-activated receptors (PPAR) ? and ?.{37274} It increases HDL secretion and expression of the lipid-related genes ABCA1, PLIN2, and ABHD5 in Caco-2/TC7 cells in a PPAR?-dependent manner. Elafibranor (10 mg/kg) decreases levels of plasma triglycerides and total cholesterol while increasing plasma HDL and expression of Acox1, a PPAR? target gene, in the liver of ApoE2-KI wild-type, but not PPAR? knockout, mice fed a Western diet. However, PPAR? knockout mice exhibit a decrease in plasma total and non-HDL cholesterol levels, indicating PPAR? has a role in these functions. Elafibranor (30 mg/kg) reduces diet-induced macro- and micro-steatosis in a PPAR?-deficient mouse model of non-alcoholic steatohepatitis.{37275} It also reduces cholesterol and triglyceride accumulation as well as macrovesicular steatosis in the liver of insulin-resistant db/db mice fed the methionine-choline deficient (MCD) diet. Formulations containing elafibranor are under clinical investigation for the treatment of non-alcoholic steatohepatitis.

We also advise you